211 filings
Page 5 of 11
DEFA14A
5p3z4j3o4pd7c
27 Apr 21
Additional proxy soliciting materials
5:19pm
8-K
o25zlefh
9 Apr 21
Entry into a Material Definitive Agreement
4:19pm
8-K
in7foriui9py
11 Mar 21
Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors
9:17am
8-K
dv6 476xfszd
26 Feb 21
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
6:29am
8-K
dg5d1e3q 3r4qi0j
5 Jan 21
Mersana Therapeutics Announces Corporate and Pipeline Updates and 2021 Goals and Anticipated Milestones
9:58am
8-K
40vqgrol1kt 4jarua
30 Nov 20
Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. as Senior Vice President
8:15am
8-K
h6e 5ilqhlly
9 Nov 20
Mersana Therapeutics Announces Third Quarter 2020 Financial Results and Provides Business Update
6:30am
8-K
qm389cja53pra 7vuh
17 Sep 20
Mersana Therapeutics Reports Updated Interim Data from the Ovarian Cancer Cohort of the XMT-1536 Phase 1 Expansion Study
6:30am
8-K
z17fycr3r29857r6 cb
3 Sep 20
Entry into a Material Definitive Agreement
6:36am
8-K
q54rljh5jbn
7 Aug 20
Mersana Therapeutics Announces Second Quarter 2020 Financial Results and Provides Business Update
6:30am
8-K
nyt7f7a3mn
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:20pm
8-K
chu7oii30 jhaegp8
1 Jun 20
Entry into a Material Definitive Agreement
5:22pm
424B5
r74jhpys
29 May 20
Prospectus supplement for primary offering
4:14pm
S-3MEF
lj951g73ho
28 May 20
Registration of additional securities for an S-3
9:41pm
424B5
ec7626j2pu98
28 May 20
Prospectus supplement for primary offering
6:08am